Gervasio Lamas is a Cardiology physician. OpenAlex indexes 369 publications with 42,736 citations (h-index 70); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4308 Alton Rd
#910
Miami Beach, FL 331402840
Telephone
305-695-0644Registry record last updated 12 Aug 2008.
Clinical trials
- Trial to Assess Chelation Therapy in Critical Limb Ischemia
Sponsor: Mt. Sinai Medical Center, Miami
- Chelation Therapy in Diabetic Patients With Critical Limb Ischemia
Sponsor: Mt. Sinai Medical Center, Miami
- Trial to Assess Chelation Therapy 2
Sponsor: Mt. Sinai Medical Center, Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20254 payments
- E.R. Squibb & Sons, L.L.C.Program year20254 payments
- HEARTFLOW, INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
50.2%Statin12.3%Rosuvastatin Calcium51%Atorvastatin Calcium49%Part D≥34 patientsBeta blocker8.1%Metoprolol Succinate38%Carvedilol35%Labetalol Hcl15%Metoprolol Tartrate12%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
14.7%Proton pump inhibitor3.8%Pantoprazole Sodium58%Omeprazole42%Part D<11 patientsGLP-1 receptor agonist3.7%Mounjaro57%Ozempic43%Part D<11 patients+ 4 more classes in this area
Blood & clotting
12%Factor Xa inhibitor8.5%Eliquis80%Xarelto20%Part D<11 patientsP2Y12 inhibitor2.3%Clopidogrel100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1995–2021 per NIH RePORTER. The latest:
- Metals in the Trial to Assess Chelation Therapy 2 (TACT2M)
Mount Sinai Medical Center (miami Beach)
FY2021$1,171,824R01AT009273 - Trial to Assess Chelation Therapy 2- TACT2 CCC
Mount Sinai Medical Center (miami Beach)
FY2021$1,153,749UH3AT009149 - Trial to Assess Chelation Therapy 2- TACT2 CCC
Mount Sinai Medical Center (miami Beach)
FY2021$915,502UH3AT009149
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association
Journal of the American Heart Association
2023 - Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met
Journal of the American Heart Association
2021 - Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy
Journal of the American College of Cardiology
2016 - Metal pollutants and cardiovascular disease: Mechanisms and consequences of exposure
American Heart Journal
2014
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”